GlobeNewswire by notified

Beter Bed Holding’s CEO John Kruijssen calls on industry to join movement and raise public awareness about importance of quality of sleep

Share

EBIA members collectively sign Sleep Manifesto to raise public sleep awareness

The quality of sleep is under pressure: while adults need an average of seven to eight hours of sleep for optimum health and well-being, more than 1 out of 3 people get less than six hours of sleep every night. This can have major consequences, for example fatigue is the main cause of driver errors in 20% of road accidents. Moreover, insufficient sleep leads to chronic health problems, such as diabetes, obesity, heart diseases and strokes. In order to address these major issues and to raise awareness about the importance of a good quality of sleep, Beter Bed Holding’s CEO, John Kruijssen, made an appeal to the industry to co-sign the Sleep Manifestoat the 23rd EBIA General Assembly in Copenhagen.

EBIA - the European Bedding Industries’ Association - represents the interests of European mattress producers and suppliers. Mattress producers, innerspring companies, textile industries, as well as PU foam and latex suppliers and representatives of the chemical industry from all over Europe were present at the EBIA General Assembly. John Kruijssen, CEO of Beter Bed Holding, appealed to the community to sign the Sleep Manifesto, referring to results of scientific research on sleep that has increased knowledge about sleep dramatically in the past years. “What if we could address prevention and improve the quality of sleep and therefore lower overall healthcare costs and increase productivity? The quality of sleep has a significant impact on productivity. In the Netherlands alone, productivity loss is estimated to equate to 1.5% to 3% of GDP per year, which is equivalent somewhere between 13 and 26 billion euro,” stated Kruijssen. “There are a lot of other major issues that we, as the European industry, need to address in order for consumers to sleep better, and therefore, live healthier, or I should say, sleep better, live better.”

Wake-up call
With the aim of helping consumers to get a better night's rest, Beter Bed launched the Sleep Manifesto earlier this month, with the aim to raise sleep awareness and improve sleep. Sleep deprivation can affect our body, brain and life expectancy. Matthew Walker, an internationally renowned sleep scientist and author of 'Why We Sleep' and TEDx speaker with more than 16 million views, recognised this problem and supported the Manifesto with his first signature. “If 50 to 60% of the entire population were to get more sleep, it would save millions of euros in healthcare spending,” said Walker while signing the Manifesto.

At the EBIA, Kruijssen called on the industry to follow in Walker’s footsteps in order to put the importance of better sleep on the agenda. The aim is to encourage better sleep behaviour and provide more information to address this social problem. “Because of the lack of awareness of the benefits of healthy sleep, multisectoral public health campaigns are needed to educate the public about the importance of sleep and the consequences of insufficient sleep,” Kruijssen stated. “Our mission is simple. We believe that the better we sleep, the happier, healthier and more productive we are. And we won’t rest until everyone gets the high-quality sleep they deserve”.

Beter Bed believes and promises that everyone can sleep better and does everything to fulfil this promise to increase public awareness of the importance of sleep, through its own platforms, but also through ambassadors and its network of specialists and scientists. Beter Bed has developed a set of innovative solutions, such as Beter Slapen ID, a measuring system that allows it to offer customers objective data-driven sleep advice. All with the aim of providing our employees and consumers with information on how to sleep better.

About Beter Bed Holding
Beter Bed Holding (BBH) is the Netherlands’ leading sleep specialist in retail, wholesale and B2B.

Our mission is simple. We believe that the better we sleep, the happier, healthier and more productivewe are. And we won’t rest until everyone gets the high-quality sleep they deserve.

Listed on Euronext Amsterdam, BBH operates the successful retail brands Beter Bed, Beddenreus, the new subscription brand Leazzzy and the digital organisation LUNEXT. In addition, through its subsidiary DBC International, BBH has a wholesale business in branded products in the bedroom furnishings sector, which includes the well-known international brand M line.

With 4 distribution centres, a fleet of 80 vehicles, 134 stores, a fast-growing online presence, and a wholesale company our team of over 1,000 dedicated employees generated € 214.2 million revenue in 2021.

Providing expert sleep advice is at the very heart of our strategy, and thanks to our revolutionary ‘Beter Slapen ID’ tool, our sleep consultants help customers to get the perfect night’s sleep. BBH is proud that M line is the official sleep supplier of AFC Ajax, TeamNL, Jumbo-Visma, NOC*NSF and the KNVB.

For more information
Press enquiries: Uneke Dekkers / CFF Communications
T +31 (0)20 575 4010 or M +31 (0)6 50261626
E uneke.dekkers@cffcommunications.nl

Please click on the link under attachments for the PDF version of the press release. 

Press photos can be downloaded here.


Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

African Development Fund mobilizes $8.9 billion for Africa’s low-income countries, the highest in its 50-year history6.12.2022 21:38:00 CET | Press release

TANGIER, Morocco, Dec. 06, 2022 (GLOBE NEWSWIRE) -- After a year of intense negotiations and a difficult global economic outlook, development partners of the African Development Fund (ADF) have agreed to commit a total package of $8.9 billion to its 2023 to 2025 financing cycle. It is the largest replenishment in the history of the Fund. ADF is the concessional window of the African Development Bank Group, providing grants and soft loans to the continent’s low-income countries. The $8.9 billion replenishment package includes $8.5 billion in core ADF funding and $429 million for the newly created Climate Action Window. ADF-16 core funding represents a 14.24% increase over ADF-15 of $7.4 billion. It is a strong endorsement of the African Development Fund and its impact in tackling the continent’s multiple development needs, including recovery from the Covid-19 pandemic, the effects of climate change, fragility, debt, and economic vulnerabilities. Algeria and Morocco contributed to the Fu

Zoltek celebrates the founder’s 80th birthday6.12.2022 20:05:26 CET | Press release

Leading the carbon fiber industry on a global scale St. Louis, Missouri, USA, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Zoltek Corporation, the largest global manufacturer of industrial grade carbon fiber, has recently celebrated the 80th birthday of its founder, Zsolt Rumy. Born in December 1942 in Budapest, Hungary, Mr. Rumy was a carbon fiber industry pioneer that ultimately changed the carbon fiber world. He created the first industrial-grade carbon fiber made to compete against other common building materials, and created Zoltek Corporation to drive the commercialization of carbon fibers. Mr. Rumy fled Soviet communism after the Hungarian Revolution in 1956, and arrived in the US as a 14-year old war refugee through the International Red Cross and Catholic Charities. He later graduated with a chemical engineering degree from the University of Minnesota, accepted a position with Monsanto Company and moved to St. Louis, Missouri in 1966. After several years of corporate sales and engineerin

Mandalay Resources Corporation tillkännager CEO-förändring och befordringar i ledningsgruppen6.12.2022 19:30:23 CET | Pressemelding

TORONTO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) tillkännagav idag att Dominic Duffy har informerat styrelsen om sitt beslut att avgå som President och Chief Executive Officer av personliga skäl. Dominic Duffy kommer att fortsätta som CEO och hjälpa till med ledarskapsövergången fram till sin avgång i juli 2023. Han kommer också att kvarstå i styrelsen i en icke-verkställande roll efter sin avgång som CEO. Mandalays styrelse har anlitat ett rekryteringsföretag för att hitta en efterträdare till Dominic Duffy. Mandalay har även nöjet att meddela att Ryan Austerberry från och med den 15 december 2022 befordras till Chief Operating Officer. Ryan Austerberry är för närvarande General Manager vid Mandalays Costerfield-gruva och var tidigare General Manager för Mandalays andra verksamma gruva, Björkdal. Adam Self, nuvarande Mine Manager på Costerfield, ersätter Ryan Austerberry som Costerfields General Manager. Br

Novartis Kisqali® prolonged PFS benefit for pre- and perimenopausal patients with aggressive HR+/HER2− metastatic breast cancer compared to chemotherapy6.12.2022 19:30:00 CET | Press release

RIGHT Choice Phase II trial is the first randomized study in patients with aggressive HR+/HER2− metastatic breast cancer (MBC), including visceral crisis, comparing a CDK4/6 inhibitor (CDK4/6i) plus endocrine therapy (ET) versus combination chemotherapy (CT)1 Kisqali plus ET demonstrated a statistically significant progression-free survival (PFS) benefit of one year compared to combination CT; data to be presented at SABCS 20221 Kisqali is a unique CDK4/6i that has consistently shown statistically significant overall survival benefit while preserving or improving quality of life across three Phase III trials in MBC, including in patients with aggressive disease1,2-13 Basel, December 6, 2022 — Novartis today announced results from the RIGHT Choice Phase II trial evaluating Kisqali® (ribociclib) plus endocrine therapy (ET) against combination chemotherapy (CT) in the first-line setting for pre- and perimenopausal patients with aggressive forms of hormone receptor-positive, human epiderma

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA6.12.2022 19:00:00 CET | Press release

Negma Group has converted 80convertible bonds in Oxurion resulting in a EUR 200,000capital increase. This is part of Negma Group’s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5billion. Leuven, BELGIUM,Boston, MA, US–December6, 2022– 07.00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Oxurion NV (Euronext Brussels: OXUR) (the “Company” or “Oxurion”), announces the below information, following the issuance of 21,008,403 new ordinary shares on December 5, 2022, for a total amount of EUR 200,000, as the result of the conversion of 80 class B convertible bonds, pursuant to the Capital Commitment entered into with Negma Group. Following completion of the capital i